v3.26.1
Nature of Operations (Details) - Theravance Biopharma, Inc
Jun. 28, 2026
USD ($)
$ / shares
Business Combination [Line Items]  
Converted share price (in dollar per share) | $ / shares $ 17.00
Percentage of shares required to approve acquisition (in percent) 66.66%
Senior Secured Notes | Senior Notes  
Business Combination [Line Items]  
Face amount | $ $ 350,000,000